Community-acquired pneumonia: Incidence, epidemiology, and current therapeutic management

Robert E. Siegel

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Improved microbiological techniques have led to the realization that as many as 30% of patients diagnosed with community-acquired pneumonia (CAP) are infected with atypical respiratory pathogens. Furthermore, antimicrobial resistance among isolates of Streptococcus pneumoniae, the leading cause of CAP, has skyrocketed in recent years. These 2 factors have contributed to the need for a reevaluation of optimal patient care.

Original languageEnglish
Pages (from-to)S529-S535
JournalAmerican Journal of Managed Care
Volume5
Issue number9 SUPPL.
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Community-acquired pneumonia: Incidence, epidemiology, and current therapeutic management'. Together they form a unique fingerprint.

Cite this